Skip to content

New EASL guidelines prioritise interferon-free hepatitis C treatment

Jean-Michel Pawlotsky presenting at the International Liver Congress. Photo by Liz Highleyman, hivandhepatitis.com

Alcohol misuse the strongest predictor of severe liver damage and death in French people with hepatitis C

Expanded vaccination and treatment could help eliminate hepatitis B worldwide

Advanced liver damage is common in people with undiagnosed hepatitis C in US survey

Grazoprevir/elbasvir highly effective in treatment-experienced and HIV-coinfected hepatitis C patients

First HIV home test approved for sale in UK

Many people living with HIV willing to take part in cure research, despite its risks

Grazoprevir / elbasvir highly effective in previously untreated hepatitis C

Men taking HIV treatment have undetectable viral loads in the rectum; sexually transmitted infections make no difference